Hormone replacement therapy in relation to the risk of colorectal cancer in women by BMI: a multicentre study with propensity score matching

被引:0
作者
Lingkai Xu
Lin Li
Dongkui Xu
Junlan Qiu
Qingting Feng
Tao Wen
Shun Lu
Fang Meng
Xiaochen Shu
机构
[1] Medical College of Soochow University,Department of Epidemiology, School of Public Health
[2] National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,VIP Department
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Oncology and Hematology
[4] the Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University,Medical Research Centre
[5] Beijing Chao-Yang Hospital,Department of Radiation Oncology
[6] Capital Medical University,Centre of Systems Medicine
[7] Sichuan Cancer Hospital/Institute,undefined
[8] University of Electronic Science and Technology of China,undefined
[9] Chinese Academy of Medical Sciences,undefined
[10] Suzhou Institute of Systems Medicine,undefined
来源
International Journal of Clinical Oncology | 2022年 / 27卷
关键词
Hormone replacement therapy; Colorectal cancer; BMI; Effect modification;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:765 / 773
页数:8
相关论文
共 111 条
  • [1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
  • [2] Bray F(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132
  • [3] Siegel RL(2000)Chemoprevention of colorectal cancer N Engl J Med 54 1960-1968
  • [4] Chen W(2005)ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components Endocr Relat Cancer 12 455-469
  • [5] Zheng R(2000)Selective loss of estrogen receptor β in malignant human colon Cancer Res 60 245-248
  • [6] Baade PD(1994)Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Nat Genet 7 536-540
  • [7] Jänne PA(2008)Colorectal cancer is a paracrine deficiency dyndrome amenable to oral hormone replacement therapy Clin Transl Sci 1 163-167
  • [8] Mayer RJ(2005)Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States) Cancer Causes Control 16 965-973
  • [9] Martineti V(2004)Estrogen plus progestin and colorectal cancer in postmenopausal women N Engl J Med 350 991-1004
  • [10] Picariello L(2002)Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 131 321-333